Franklin Street Advisors’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-13,590
| Closed | -$48K | – | 165 |
|
|
2019
Q1 | $48K | Hold |
13,590
| – | – | 0.01% | 155 |
|
|
2018
Q4 | $54K | Buy |
13,590
+660
| +5% | +$2.62K | 0.01% | 142 |
|
|
2018
Q3 | $255K | Buy |
12,930
+10,400
| +411% | +$205K | 0.03% | 137 |
|
|
2018
Q2 | $80K | Sell |
2,530
-80
| -3% | -$2.53K | 0.01% | 155 |
|
|
2018
Q1 | $97K | Buy |
2,610
+28
| +1% | +$1.04K | 0.01% | 157 |
|
|
2017
Q4 | $204K | Buy |
+2,582
| New | +$204K | 0.03% | 155 |
|